Call for Abstract

35th World Vaccines & Immunization Congress , will be organized around the theme “Scrutinizing Recent Advancements in Vaccines & Immunization

Venue: The Park Hotel Brisbane, Australia

Vaccines & Immunization 2019 is comprised of 20 tracks and 135 sessions designed to offer comprehensive sessions that address current issues in Vaccines & Immunization 2019.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Vaccines play an important role in keeping us healthy. They protect us from serious and sometimes deadly diseases like haemophilus influenzae type b (Hib) and is made from very small amounts of weak or dead germs that can cause diseases for example, viruses, bacteria, or toxins. It prepares your body to fight the disease faster and more effectively so you won’t get sick. The challenge in vaccine development consists in devising a vaccine strong enough to ward off infection without making the individual seriously ill. To that end, researchers have devised different types of vaccines


  • Track 1-1Vaccine Development
  • Track 1-2Vaccines Recommendations
  • Track 1-3Vaccine Storage and Handlings
  • Track 1-4Missing Vaccinations Harms
  • Track 1-5Vaccine Ingredients
  • Track 1-6Next Generation Vaccines
  • Track 1-7Vaccines Misperception and Side Effects
  • Track 1-8 Different Types of Vaccines
  • Track 1-9• Egg-based vaccines • Mammalian cells-based vaccines • Production using plant, insect cells or bacteria cultures • Investigational vaccines manufacture • Clinical development of vaccines

The use of vaccines has led to major improvements in child health over a relatively short period. Many of the infectious illnesses you or your parents had as children, from chickenpox to polio to measles, no longer affect most children today. Immunization is a process that helps your body fight off diseases caused by certain viruses and bacteria, by exposing your body to vaccines, usually by injections. These vaccines contain tiny amounts of material that make your immune system produce certain substances called antibodies.


  • Track 2-1Diphtheria and Tetanus Vaccine
  • Track 2-2Chickenpox Vaccine
  • Track 2-3Hepatitis A and Hepatitis B Vaccine
  • Track 2-4Shingles (Herpes zoster) Vaccine
  • Track 2-5Rabies Vaccines and Rotavirus Vaccine
  • Track 2-6Measles, Mumps, Rubella and Varicella (MMRV) Vaccine
  • Track 2-7Pneumococcal Vaccines and Meningococcal Vaccines
  • Track 2-8Haemophilus Influenzae Type b (Hib) Containing Vaccines
  • Track 2-9Diphtheria, Tetanus and Whooping Cough Combination Vaccines
  • Track 2-10Polio Vaccine and Flu Vaccine

When this system is exposed to molecules that are foreign to the body, called non-self, it will orchestrate an immune response, and it will also develop the ability to quickly respond to a subsequent encounter because of immunological memory. This is a function of the adaptive immune system. Therefore, by exposing an animal to an immunogen in a controlled way, its body can learn to protect itself: this is called active immunization


  • Track 3-1Immune Dysfunction and Clinical Immunology
  • Track 3-2Nutritional Immunology and Basic Immunology
  • Track 3-3Immunostimulants and Immune Globulins
  • Track 3-4Immunity to Bacteria,Fungi,Viruses
  • Track 3-5Immunodiagnostic Techniques
  • Track 3-6Veterinary Immunology
  • Track 3-7Immunotherapy
  • Track 3-8Hypersensitivity
  • Track 3-9Immunodeficiency
  • Track 3-10Theoretical immunology

The major goals of veterinary vaccines are to improve the health and welfare of companion animals, increase production of livestock in a cost-effective manner, and prevent animal-to-human transmission from both domestic animals and wildlife. These diverse aims have led to different approaches to the development of veterinary vaccines from crude but effective whole-pathogen preparations to molecularly defined subunit vaccines, genetically engineered organisms or chimeras, vectored antigen formulations, and naked DNA injections. The final successful outcome of vaccine research and development is the generation of a product that will be available in the marketplace or that will be used in the field to achieve desired outcomes. As detailed in this review, successful veterinary vaccines have been produced against viral, bacterial, protozoal, and multicellular pathogens, which in many ways have led the field in the application and adaptation of novel technologies



  • Track 4-1Veterinary Vaccines for Non Infections Diseases
  • Track 4-2Vector-based Veterinary Vaccines
  • Track 4-3Development of Veterinary Vaccines
  • Track 4-4Safety or Efficacy of a Veterinary Medicine
  • Track 4-5Vaccines for Livestock Diseases
  • Track 4-6Animal Health Outcomes and Advances
  • Track 4-7Case Reports in Animal Vaccination
  • Track 4-8Types of Veterinary Vaccines

Infectious diseases are disorders caused by organisms such as bacteria, viruses, fungi or parasites. Many organisms live in and on our bodies. They're normally harmless or even helpful, but under certain conditions, some organisms may cause disease. According to the World Health Organization, as of 2011 there were 12,420 different diseases and health-related ailments. In other words, you should be thanking your immune system and modern medicine before you go to sleep each and every night. Of those numerous diseases, perhaps none is more common than infectious diseases, which are defined by WHO as "any pathogenic microorganism that can be spread directly or indirectly from one person to another."

  • Track 5-1Anthrax Vaccines
  • Track 5-2Pertussis Vaccines
  • Track 5-3Tuberculosis Vaccines and Hepatitis Vaccines
  • Track 5-4Pneumococcal Vaccines and Meningococcal Vaccines
  • Track 5-5Typhoid Fever Vaccines and Influenza Vaccines
  • Track 5-6Japanese Encephalitis Vaccines
  • Track 5-7Yellow fever Vaccines and Dengue Fever Vaccines
  • Track 5-8Rotavirus Gastroenteritis Vaccines
  • Track 5-9Human Papilloma-Virus Vaccines
  • Track 5-10Varicella and Herpes Zoster (shingles) Vaccines
  • Track 5-11Haemophilus Influenza Type B Vaccines
  • Track 5-12Tick-Borne Encephalitis Vaccines
  • Track 5-13Vaccines for Emerging & Re-Emerging Diseases

Plants can churn out lots of recombinant proteins, and these proteins aren’t contaminated with animal proteins. Plant-based vaccines are recombinant protein subunit vaccines. The challenges facing plant-based vaccine development include technical, regulatory and economic aspects and public perception. In the technical challenges it is very difficult to select a plant system where it grows under optimized conditions to minimize the environmental risks. Ideally, the plant species choice used to produce the selected antigen should applicable for oral drug delivery in an edible vaccine form. To date, the most advanced human vaccine projects have successfully completed phase I clinical trials, & animal vaccine projects have given promising data in early phase trials targeting the specific animal species.


  • Track 6-1Production of Plant based Vaccine
  • Track 6-2Biotherapeutics of Plant Vaccine
  • Track 6-3Plant based Vaccine against Virus
  • Track 6-4Molecular level of Plant based Vaccine
  • Track 6-5Direct Gene Delivery Method
  • Track 6-6Disadvantages of Plant Based Vaccines
  • Track 6-7Methods to Increase the Efficiency of Gene Delivery

Immunology charts, measures, and contextualizes the: physiological functioning of the immune system in states of both health and diseases malfunctions of the immune system in immunological disorders such as autoimmune diseases hypersensitivities immune deficiency, and transplant rejection the physical, chemical and physiological characteristics of the components of the immune system in vitro, in situ, and in vivo. Immunology has applications in numerous disciplines of medicine, particularly in the fields of organ transplantation, oncology, rheumatology, virology, bacteriology, parasitology, psychiatry, and dermatology

  • Track 7-1Classical Immunology
  • Track 7-2Clinical immunology
  • Track 7-3Developmental immunology
  • Track 7-4Eco immunology and Behavioural Immunity
  • Track 7-5Immunotherapy
  • Track 7-6Diagnostic Immunology
  • Track 7-7Cancer Immunology
  • Track 7-8Reproductive Immunology
  • Track 7-9Theoretical immunology

Immunology is worried about the utilization of immunological responses for the determination, avoidance, and treatment of various infections. It is firmly identified with therapeutic and veterinary microbiology, the study of disease transmission, physiology and Pathophysiology, organic chemistry, and endocrinology. Viral Immunology and the immunology of parasitic infections are autonomous branches of common sense immunology. Immunology concentrates the antigenic creation of microorganisms, attributes of the safety procedures in different sorts of contaminations, and nonspecific types of Imperviousness to the causative operators of irresistible infections. Investigation of the immunological procedures and the immunological reproduction of the living being created by Non-infectious Antigens of the exogenous and endogenous starting point and the advancement of strategies for controlling unfavourably susceptible sicknesses are winding up noticeably progressively imperative articles, symposia, publications, and hypothetical expositions

  • Track 8-1Antibody Engineering & Technology
  • Track 8-2Novel Approaches & Technology Development
  • Track 8-3Nano-Immunotechnology
  • Track 8-4 IgA Ligand
  • Track 8-5Affibody-Fusions
  • Track 8-6Immunological Assay
  • Track 8-7Transcriptomics & Immunodiagnostic
  • Track 8-8Antigen-Antibody Interactions

The immune system has the capacity to mount an immune response to virtually all molecules and/or cells. Although the capacity to respond to self-antigen is present in all of us, in most instances such responses result in tolerance, indicating that mechanisms must exist to prevent or subdue autoimmune responses. Moreover, auto-reactive T and B cells, as well as autoantibodies, are found in people who do not have autoimmune diseases, demonstrating that immunological auto-reactivity alone is not sufficient for the development of the disease. The mechanisms currently thought to prevent/dampen autoimmune responses include inactivation or deletion of autoreactive B and T cells, active suppression by cells or cytokines, idiotype or anti-idiotype interactions, and the immunosuppressive adrenal hormones, the glucocorticoids. When dampening mechanisms fail or are overridden, a response directed against self-antigen can occur, resulting in autoimmune diseases that range from those which are organ-specific (diabetes and thyroiditis) to those which are systemic (non-organ specific) such as systemic lupus erythematosus and rheumatoid arthritis.


  • Track 9-1Autoimmune Research
  • Track 9-2Inflammation
  • Track 9-3Immunometabolism & Its Regulator
  • Track 9-4Immunomodulatory Effects on Immune System
  • Track 9-5Immunotherapy
  • Track 9-6Radio Immunotherapy & Cancer Vaccines Development
  • Track 9-7Current Evidence and Future Perspectives of Autoimmunity
  • Track 9-8Future Immunomodulation Strategies
  • Track 9-9Immunomodulatory Xenobiotics

The immune system has developed a variety of approaches to controlling viral and bacterial infection, which range from direct killing of pathogen to elaborating cytokines that inhibit replication.  Pathogens have countered by developing a variety of immune evasion mechanisms that inhibit cytokine function and prevent immune recognition of infected cells.  Faculty and student efforts to define and characterize these opposing mechanisms will undoubtedly lead to improved treatment of infectious diseases ranging from AIDS and parasitic infections to sexually transmitted diseases and the common cold.


  • Track 10-1Primary immune deficiency diseases
  • Track 10-2Scleroderma and Lupus
  • Track 10-3Autoimmune lymphoproliferative Syndrome
  • Track 10-4Type one diabetes and Vasculitis
  • Track 10-5 Graves Disease
  • Track 10-6Rheumatoid Arthritis
  • Track 10-7Multiple Sclerosis
  • Track 10-8Pernicious Anaemia
  • Track 10-9Hyper-Immunoglobulin E Syndrome

A session plan lists all communities served by the health centre and specifies how frequently each community will be reached based on such factors as distance, target population, workload and other relevant operational issues. This section provides an example format and gives a simple method for choosing session frequency, scheduling dates and organizing the supplies needed to complete a session plan that reaches every community in a health centre catchment area. It is based on a maximum workload of about 30 infants per vaccinator per session. It uses an immunization schedule that requires a minimum of four contacts during the first year of life. The aim is to plan sessions so that staff time is used efficiently.


  • Track 11-1Immunization Session plan
  • Track 11-2Health Centre Outreach Session Plan
  • Track 11-3Immunization Session Supplies
  • Track 11-4Health Centre Monthly Stock Report
  • Track 11-5Managing an Immunization Session
  • Track 11-6 Calculations used in Determining needed Session Frequency

Immunization is a routine procedure for health workers, but can be frightening for children and adults attending the session. There are many things a health worker can do to make an immunization experience a safe and positive one. This section focuses on techniques for injection preparation, the comfortable and safe positioning of children, and the safe disposal of materials.


  • Track 12-1Preparing to Vaccinate
  • Track 12-2Subcutaneous (SC) Injection in the Upper Arm
  • Track 12-3Intradermal (ID) Injection
  • Track 12-4Good Injection Technique
  • Track 12-5Good Oral Administration Technique
  • Track 12-6Positioning the Infant for Vaccination
  • Track 12-7Good General Techniques
  • Track 12-8Making Vaccination Easier and more Comfortable
  • Track 12-9Reconstituting Vaccines and Steps for Reconstitution
  • Track 12-10Intramuscular (IM) Injection in Infants

The most vital achievements of the previous century included the development of vaccines to ensure against infections: smallpox, polio, hepatitis, human papillomavirus (HPV), and even chickenpox. Be that as it may, one infection stays slippery to those looking to make an immunization to prepare for it: HIV. Getting immunized ahead of schedule, before sexual introduction, is additionally viable in keeping certain kinds of STIs. Vaccines are available to prevent human papillomavirus (HPV), hepatitis A and hepatitis B.


Vaccine development is an activity that focuses on a variety of technological initiatives and applied research, which upgrade and advance enhanced frameworks and practices for vaccine safety. In the previous year, the exceptional Ebola sickness flare-up aroused research and industry reaction and as we keep on scanning for arrangements, we should audit the exercises learned with the end goal to beat the flow challenges. Vaccine development is a long, complex process, frequently enduring 10-15 years and including a mix of open and private contribution. The present framework for creating, testing, and directing immunizations created amid the twentieth century as the gatherings included institutionalized their methods and controls.


  • Track 14-1Egg-based vaccines
  • Track 14-2Mammalian cells-based vaccines
  • Track 14-3Production using plant, insect cells or bacteria cultures
  • Track 14-4Investigational vaccines manufacture
  • Track 14-5Clinical development of vaccines

 Patients with immune-mediated inflammatory diseases (IMID), for example, RA, IBD or psoriasis, are at expanded danger of contamination, in part in light of the ailment itself, yet for the most part on account of treatment with immune-modulatory or immunosuppressive drugs. Regardless of their raised hazard for vaccine-preventable disease, immunization inclusion in IMID patients is surprisingly low. Despite the fact that the decreased nature of the resistant reaction in patients under immunotherapy negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for <span background-attachment:="" background-clip:="" background-origin:="" background-position:="" background-repeat:="" background-size:="" hepatitis="" span="" style="\" background-image:"="">Influenza and Pneumococcal vaccination Innate immunity and diabetes vaccines


  • Track 15-1Vaccines for immunodeficiency diseases
  • Track 15-2Vaccination strategy in patients with IMID
  • Track 15-3Vaccinations in patients with immune-mediated inflammatory diseases
  • Track 15-4Central nervous system-targeted & Tissue-specific autoimmunity
  • Track 15-5Vaccines for autoimmune skin disorders & neuropathies
  • Track 15-6Vaccine safety: impact on disease activity in IMID patients

The notable application in Cancer Immunology is Cancer Immunotherapy. Knowledge of the essential systems of tumor immunology has been expanding quickly. The flow look into and new discoveries have made these progressions in to achievement for some tumors. Oncologist expects to know the connection among growths and the ordinary invulnerable framework. The atomic distinguishing proof of malignancy antigens, Cytokine quality move into growth cells, supportive exchange of invulnerable effector cells are a portion of the ongoing advancement in tumor immunology.

  • Track 16-1Cancer Immunodiagnostics
  • Track 16-2Tumour Immunization
  • Track 16-3Molecular Cancer Therapeutics

The Live-Attenuated vaccine is produced to the disease caused by Zika Virus. The monovalent form of the antibody is outlined against Zika infection contamination. Zika Virus has a place with the Genus Flavivirus, or, in other words the Aedes mosquitos. The comprehension of flavivirus molecule structure, meaning of E dimers as the key antigenic target, and profound comprehension of balance systems help to build up the antibody.

  • Track 17-1Zika Virus Vaccines Clinical Trials
  • Track 17-2Zika Virus Vaccine Development
  • Track 17-3Zika Virus Vaccines Recent Research
  • Track 17-4Purified Inactivated Vaccine

Hepatitis B vaccinations are made out of the hepatitis B disease surface antigen (HbsAg), a protein made by hepatitis B contamination. Earlier inoculation things were made using cleansed plasma of polluted individuals. This creation procedure has been supplanted by recombinant development that can convey HbsAg without requiring human plasma extending the security of the vaccination by banishing the peril from potential spoiling of human plasma.

  • Track 18-1Public health concerns in vaccination
  • Track 18-2Contraindications - Vaccines, vaccination
  • Track 18-3Vaccines formulation and technologies used in conjugated vaccines

Tuberculosis (TB) Vaccines are inoculations expected for the neutralizing activity of tuberculosis. Around three out of each 10,000 people who get the counter acting agent experience indications, which are typically minor beside in to a great degree immuno-debilitated individuals. While BCG immunization gives really successful protection to infant youngsters and energetic kids, its ampleness in adults is variable, running from 0% to 80%. A few variables have been considered as accountable for the evolving results. Interest for TB immunotherapy movement exists because the infection has advanced toward winding up continuously sedate safe.

  • Track 19-1Antituberculous Vaccine Development
  • Track 19-2Pulmonary Vaccines
  • Track 19-3Pre-infection TB Vaccine

Toxoid immunizations are delivered utilizing a toxic substance (harm) that has been made safe anyway that moves a safe response against the toxic substance. depend upon the toxic substance made by particular microorganisms (e.g. tetanus or diphtheria). The toxic substance assaults the circulatory framework and is, all things considered, accountable for the reactions of the illness. The protein-based toxic substance is rendered harmless and used as the antigen in the vaccination to bring out resistance.

  • Track 20-1Allergic reactions
  • Track 20-2Hypersensitivity
  • Track 20-3Biotherapeutics